Intelligent Medicine Total Debt vs. Number Of Employees
| IQMDWDelisted Stock | USD 0 0.00 0.00% |
For Intelligent Medicine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Intelligent Medicine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Intelligent Medicine Acquisition utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Intelligent Medicine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Intelligent Medicine Acquisition over time as well as its relative position and ranking within its peers.
Intelligent |
Intelligent Medicine Number Of Employees vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Intelligent Medicine's current stock value. Our valuation model uses many indicators to compare Intelligent Medicine value to that of its competitors to determine the firm's financial worth. Intelligent Medicine Acquisition is considered the number one company in total debt category among its peers. It also is currently regarded as number one stock in number of employees category among its peers . The ratio of Total Debt to Number Of Employees for Intelligent Medicine Acquisition is about 165,000 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Intelligent Medicine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Intelligent Total Debt vs. Competition
Intelligent Medicine Acquisition is considered the number one company in total debt category among its peers. Total debt of Shell Companies industry is currently estimated at about 6.92 Billion. Intelligent Medicine adds roughly 165,000 in total debt claiming only tiny portion of equities listed under Shell Companies industry.
Intelligent Number Of Employees vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Intelligent Medicine |
| = | 165 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Intelligent Medicine |
| = | 1 |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Intelligent Number Of Employees vs Competition
Intelligent Medicine Acquisition is currently regarded as number one stock in number of employees category among its peers. The total workforce of Shell Companies industry is currently estimated at about 50,741. Intelligent Medicine adds roughly 1.0 in number of employees claiming only tiny portion of equities listed under Shell Companies industry.
Intelligent Medicine Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Intelligent Medicine, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Intelligent Medicine will eventually generate negative long term returns. The profitability progress is the general direction of Intelligent Medicine's change in net profit over the period of time. It can combine multiple indicators of Intelligent Medicine, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Intelligent Medicine Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2021 and is based in Bethesda, Maryland. Intelligent Medicine is traded on NASDAQ Exchange in the United States.
Intelligent Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Intelligent Medicine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Intelligent Medicine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Intelligent Medicine's important profitability drivers and their relationship over time.
Use Intelligent Medicine in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Intelligent Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intelligent Medicine will appreciate offsetting losses from the drop in the long position's value.Intelligent Medicine Pair Trading
Intelligent Medicine Acquisition Pair Trading Analysis
The ability to find closely correlated positions to Intelligent Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intelligent Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intelligent Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intelligent Medicine Acquisition to buy it.
The correlation of Intelligent Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intelligent Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intelligent Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Intelligent Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Intelligent Medicine position
In addition to having Intelligent Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Picks Thematic Idea Now
Macroaxis Picks
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Intelligent Stock
If you are still planning to invest in Intelligent Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intelligent Medicine's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |